Robinson investigates how care models influence incretin therapy outcomes
Incretin-based therapies, such as GLP-1s and GIPs, have transformed treatment for people with Type II Diabetes (T2D) and obesity. In turn, many clinicians have harnessed…
Incretin-based therapies, such as GLP-1s and GIPs, have transformed treatment for people with Type II Diabetes (T2D) and obesity. In turn, many clinicians have harnessed…
When a patient’s alcohol use contributes to liver injury, the clinical response may appear straightforward: advise abstinence to prevent further damage. However, in hepatology and…
Earlier this month, it was announced that after more than 20 years as medical director of University of Iowa Health Care’s Medical Intensive Care Unit…
UI Health Care’s supportive culture drew Nicholas Arnold, MD, back to Iowa after completing fellowship training elsewhere—a return that ultimately positioned him for hospital leadership….
When asked how she balances work as both a clinician and researcher, Nicole Fleege, MD, doesn’t hesitate: her patients always come first. Now, two prestigious…
Internal Medicine placed 96 clinicians on the list of Patient’s Choice Award recipients for their excellence in patient care in Fiscal Year 2025 (July 1,…
The Medical Intensive Care Unit (MICU) at UI Health Care has thrived under the steady leadership of Kevin C. Doerschug, MD, MS, who has served…
There is no one-size-fits-all approach to weight management, but recent advancements in GLP-1 based medications offer a new treatment opportunity for patients with obesity and…
As waiting lists for lung transplants grow, so does the demand for robust and trustworthy transplant programs in the United States. Since opening in 2007,…
The relationship between diabetes and the cardiovascular system has been extensively studied, but far less is known about how type 1 diabetes (T1D) affects the…